News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cebix Raises $16M From Investors



9/2/2010 8:14:57 AM

Xconomy -- San Diego-based Cebix, which is developing a replacement therapy based on human proinsulin C-peptide as a supplemental treatment for complications from type 1 diabetes, has raised $16 million over the past 14 months, according to a form filed with regulators Monday. The form amends a regulatory filing that Cebix submitted in June, 2009, which disclosed it had raised almost $2.3 million. The two-year-old startup has made no announcements about the funding or investors, but representatives of Sofinnova Ventures, InterWest Partners, Thomas McNerny & Partners, and Creative Peptides of Stockholm, Sweden, are on its board.

Read at Xconomy


comments powered by Disqus
Xconomy
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES